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ABSTRACT Mucosal immunity to the enteric pathogen Shigella flexneri is mediated by secretory IgA (S-IgA) antibodies directed
against the O-antigen (O-Ag) side chain of lipopolysaccharide. While secretory antibodies against the O-Ag are known to pre-
vent bacterial invasion of the intestinal epithelium, the mechanisms by which this occurs are not fully understood. In this study,
we report that the binding of a murine monoclonal IgA (IgAC5) to the O-Ag of S. flexneri serotype 5a suppresses activity of the
type 3 secretion (T3S) system, which is necessary for S. flexneri to gain entry into intestinal epithelial cells. IgAC5’s effects on the
T3S were rapid (5 to 15 min) and were coincident with a partial reduction in the bacterial membrane potential and a decrease in
intracellular ATP levels. Activity of the T3S system returned to normal levels 45 to 90 min following antibody treatment, demon-
strating that IgAC5’s effects were transient. Nonetheless, these data suggest a model in which the association of IgA with the
O-Ag of S. flexneri partially de-energizes the T3S system and temporarily renders the bacterium incapable of invading intestinal
epithelial cells.
IMPORTANCE Secretory IgA (S-IgA) serves as the first line of defense against enteric infections. However, despite its well-
recognized role in mucosal immunity, relatively little is known at the molecular level about how this class of antibody functions
to prevent pathogenic bacteria from penetrating the epithelial barrier. It is generally assumed that S-IgA functions primarily by
“immune exclusion,” a phenomenon in which the antibody binds to microbial surface antigens and thereby promotes bacterial
agglutination, entrapment in mucus, and physical clearance from the gastrointestinal tract via peristalsis. The results of the pres-
ent study suggest that in addition to serving as a physical barrier, S-IgA may have a direct impact on the ability of microbial
pathogens to secrete virulence factors required for invasion of intestinal epithelial cells.
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Shigella flexneri is the causative agent of bacillary dysentery, aninvasive disease of the colonic mucosa that afflicts more than a
million children each year (1). Like Salmonella and other related
Gram-negative bacterial pathogens, S. flexneri penetrates intesti-
nal epithelial cells by virtue of a type 3 secretion (T3S) system, a
macromolecular protein transport apparatus that is structurally
and genetically related to bacterial flagella (2). Upon contact with
epithelial cells, the T3S apparatus injects effector proteins, also
known as the invasion plasmid antigens (e.g., IpaB, IpaC, and
IpaD), into host cells, resulting in cytoskeletal rearrangements and
bacterialmacropinocytosis. Assembly and function of theT3S sys-
tem are regulated in response to physical and environmental sig-
nals that the bacterium encounters in the gastrointestinal tract (3,
4).
In humans, protective immunity to S. flexneri is strongly cor-
related with secretory IgA (S-IgA) antibodies directed against the
serotype-specificO-antigen (O-Ag) side chains of lipopolysaccha-
ride (1, 5). In experimental models of shigellosis, it has been
shown that passivemucosal administration of amurinemonoclo-
nal dimeric/polymeric IgA (MAb) known as IgAC5, directed
against the O-Ag of S. flexneri serotype 5a, is sufficient to protect
otherwise naive animals against infection (6, 7). Protection occurs
at mucosal surfaces, as IgAC5-coated bacteria are demonstrably
less invasive than their uncoated counterparts (7). Because IgAC5
is neither bactericidal nor bacteriostatic, IgAC5’s protective effects
have been attributed in part to the ability of the antibody to pro-
mote bacterial entrapment in mucus, a phenomenon known as
“immune exclusion” (7, 8). However, whether IgAC5 has addi-
tional effects on S. flexneri that contribute to protection of intes-
tinal epithelial cells has not been determined.
Recent work from our laboratory has suggested that exposure
of a related bacterium, Salmonella enterica serovar Typhimurium,
to anO-Ag-specific IgA under nonagglutinating conditions is suf-
ficient to prevent bacterial invasion of intestinal epithelial cells,
possibly through interference with the T3S system (9, 10). For this
reason, we sought to examine the impact of IgAC5 onT3S system-
mediated export of Ipa proteins by S. flexneri. Strain M90T (1 
109 CFU perml) was treated with IgAC5 (2 to 5g/ml) for 15min
prior to being exposed to Congo red (CR), a gratuitous inducer of
S. flexneri type 3-mediated Ipa secretion (11). There was amarked
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reduction (90%) in IpaB levels in the supernatants of cultures
that had been treated with IgAC5 and CR, compared to superna-
tants from cells treated with CR only (Fig. 1A). Corresponding
analysis of total cell lysates revealed that, following IgAC5 treat-
ment, IpaB remained associated with the cell pellet (Fig. 1B). The
reduction in IpaB secretion by IgAC5 was roughly equivalent to
that achieved by treatment with the proton ionophore carbonyl
cyanide m-chlorophenylhydrazone (CCCP; Sigma-Aldrich, St.
Louis, MO) (Fig. 1A and B, lane 6). Surprisingly, however, we also
noted that IpaB levels were markedly reduced (45%) upon ex-
posure of S. flexneri to several isotype controlMAbs, like TEPC-15
(Fig. 1A andB, lane 3). This result suggests that IgA, irrespective of
the variable region (Fv), interferes to some degree with T3S activ-
ity. This finding further expands a role for S-IgA in innate immu-
nity at mucosal surfaces and may explain the observation by Wi-
jburg and colleagues that T3S-mediated invasion of intestinal
epithelial cells by S. Typhimurium is suppressed ~5-fold by IgA
antibodies from naive mice (12, 13).
Therefore, to discern the specific contribution of the antibody-
variable (Fv) region of IgAC5 on effector secretion by S. flexneri,
IpaB levels were subsequently normalized to an isotype control
MAb. A dose-response experiment revealed that IgAC5 reduced
FIG 1 IgAC5 suppresses secretion of Ipa proteins by S. flexneri. A total
of 1  109 CFU per ml of mid-log-phase cultures of S. flexneri strain
M90T was treated with IgAC5, control IgA MAbs (e.g., TEPC-15 and
Sal4), O-Ag polyclonal rabbit antisera, or CCCP for the indicated times
prior to the addition of Congo red (CR; 6 g/ml) to trigger T3S system-
mediated Ipa transport. Ten minutes later, the bacterial cultures were
subjected to centrifugation (5 min at 8,000 relative centrifugal force
[RCF]). The resulting supernatants were passed through a 0.2-m filter
to remove any contaminating bacterial cells, concentrated with trichlo-
roacetic acid, solubilized in Laemmli sample buffer containing
-mercaptoethanol (-ME; 5% [vol/vol]), and then analyzed by SDS-
PAGE and Western blotting (W.B.) with murine IgG MAbs specific for
IpaB or IpaC (as indicated) and chemiluminescent detection (Bio-Rad,
Hercules, CA). The amount of IpaB or IpaC was determined by densito-
metric analysis of the Western blot films. IpaB and IpaC amounts below
the level of detection were set to 1. For panel B only, the bacterial pellets
were lysed by the addition of 2 Laemmli sample buffer with -ME and
subjected to SDS-PAGEandWestern blotting, as indicated above. (A and
B) Supernatants (A) or bacterial pellets (B) from cultures were treated as
follows: lane 1, no treatment; lane 2, no treatment followed byCR; lane 3,
TEPC-15 (5 g/ml) for 15 min followed by CR; lane 4, IgAC5 (2 g/ml)
for 15 min followed by CR; lane 5, IgAC5 (5 g/ml) for 15 min followed
by CR; lane 6, CCCP (100 M) for 15 min followed by CR. The relative
amounts of IpaB in the cell supernatants are indicated across the top of
the panel as “% control.” In this case, the control was the amount of IpaB
associated with CR-treated cells (lane 2). (C)Dose-dependent inhibition
of IpaB secretion by IgAC5. Shown are IpaB levels in the supernatants of
cultures of S. flexneri M90T treated for 15 min with the indicated con-
centrations of IgAC5or the S. Typhimurium-specific IgAMAbSal4 prior
to the addition of CR. Cells treated with SalIV and CR (lane 5) served as
the positive control for this experiment, and the amounts of IpaB in the
supernatants are expressed as a percentage of this control. (D) IpaC
secretion is inhibited by O-Ag polyclonal antibodies (PAbs). Cultures of
S. flexneri were treated with 2.5 or 5 g/ml O-Ag PAbs or CCCP
(100 M) for 15 min prior to the addition of CR. Culture supernatants
were prepared as indicated above and blotted with an IpaC-specific
MAb. The vertical line between lanes 2 and 3 indicates that a lane(s)
present in the original Western blot at this location was removed from
the final image. The removed lane(s) represents experimental conditions
that were not relevant to the figure. (E to F) IgAC5’s effects on Ipa secre-
tion are transient. Cultures of S. flexneri were treated with IgAC5 (5 g/
ml), O-Ag PAbs (5g/ml), or CCCP (100M) for 45min (E) or 90min
(F) prior to the addition of CR. Culture supernatants were then blotted
with an IpaB-specific MAb. The elevated levels of IpaB in the negative
control samples (lanes 1) in these experiments (compared to those de-
scribed in panels A toD) reflect the baseline accumulation of the proteins
in culture supernatants over the prolonged course of the experiments (45
and 90 min in panels E and F, compared to 15 min for experiments
described in panels A to D). (G) Dose-dependent inhibition of Ipa secre-
tion byCCCP. Cultures of S. flexneriwere treatedwith indicated concen-
trations CCCP for 15 min prior to the addition of CR, after which cell
supernatants were blotted for IpaC.
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IpaB secretion by 65%, compared to a control MAb, thereby
demonstrating the importance of O-Ag recognition in suppres-
sion of T3S activity (Fig. 1C). The contribution of the Fv region
was further underscored by the observation that IpaB secretion
into culture supernatants following CR treatment was reduced to
baseline levels in the presence of rabbit polyclonal O-Ag-specific
IgG antiserum (BD Diagnostic Systems, Sparks, MD) (Fig. 1D).
Interestingly, the inhibitory effects of both IgAC5 and polyclonal
O-Ag antiserum were transient, as secretion of IpaB levels re-
turned to normal 45 min after IgAC5 treatment (Fig. 1E and F,
lane 3) and ~90 min after polyclonal O-Ag antiserum exposure
(Fig. 1E and F, lane 4). The prolonged blocking of Ipa secretion in
the presence of antiserum might be due the diversity of epitopes
recognized by the IgG antibody molecules, as opposed to the sin-
gle epitope recognized by IgAC5.
The observation that exposure of S. flexneri to IgAC5 resulted
in a loss in T3S activity led us to postulate that antibody binding to
theO-Agmay partially de-energize the electropotential of the bac-
terial membrane. We were particularly interested in the effect of
IgAC5 on the proton motive force (PMF) and intracellular ATP
levels, because the PMF and/or ATP levels have been implicated in
powering the T3Smachinery in several enterobacteria (14–17). To
first define the relationship between Ipa secretion and PMF in
S. flexneri, we subjected bacterial cells to escalating doses of the
proton ionophore CCCP and then examined both IpaC secretion
and PMF. PMF, or more specifically the membrane potential
() component of PMF, was estimated by using the cationic dye
JC-1 (Invitrogen, Carlsbad, CA), essentially as done previously
(18, 19). As expected, CCCP treatment resulted in a dose-
dependent reduction in CR-mediated IpaC secretion (Fig. 1G).
Correspondingly, CCCP treatment resulted in a time- and dose-
dependent decrease in membrane potential (Fig. 2A). ATP levels
also plummeted following CCCP treatment, although levels re-
covered with time, probably reflecting S. flexneri’s capacity to re-
generate ATP in the absence of an intact PMF (Fig. 2B) (20).
Having established a correlation between S. flexneri’s bioener-
getic state and Ipa secretion, we next examined the effect of IgAC5
on PMF and ATP levels. We observed that treatment of S. flexneri
with IgAC5 was accompanied by a dose- and time-dependent re-
duction in membrane potential (Fig. 2A). For example, exposure
of cells to 10 g/ml IgAC5 resulted in a reduction in  ranging
from25 to 40%andwas accompanied by a coincident decrease (20
to 25%) in ATP levels (Fig. 2B), supporting our hypothesis that
IgAC5 affects the electropotential of the S. flexneri cell envelope.
However, treatment of cells with 5 g/ml IgAC5 only marginally
reduced  (5 to 10%), despite the fact that 5 g/ml IgAC5 was
previously shown to be sufficient to suppress Ipa secretion to vir-
tually undetectable levels (Fig. 1). We postulate that this apparent
inconsistency is due to the relatively high threshold required to
promote JC-1 aggregation inside cells (21) and the exquisite sen-
sitivity of the Ipa T3S system to the physiologic state of the cell (3).
On the other hand, we cannot rule out the possibility that IgAC5
not only perturbs membrane potential but also interferes with the
T3S system by an additional mechanism related to its ability to
physically associate with the O-Ag. Indeed, the observation that
1MCCCP reduced bacterial membrane potential by20% but
only reduced IpaC secretion by 50% (compare Fig. 1G and 2A)
reveals that bioenergetics alone may not explain IgAC5’s full im-
pact on T3S.
Although it remains unclear from this study exactly how the
association of IgAC5 with the O-Ag leads to alterations in Ipa
secretion and changes in membrane potential, there are signal
transduction pathways and mechanosensitive channels localized
in the periplasm and inner membrane dedicated to “sensing”
changes at the cell surface (22, 23). IgAC5, by virtue of its ability to
bind and cross-link the O-Ag, may induce a type of outer mem-
brane “stress” that effectively destabilizes the outer leaflet of the
outer membrane (24). Triggering of membrane stress response
pathways (23) and/or mechanosensitive channels (22) could di-
rectly or indirectly impact the PMF and activity of the T3S system.
In support of an antibody-mediated membrane stress model, we
have recently described distinct ultrastructural changes in the
outermembrane of S. Typhimuriumassociatedwith exposure to a
FIG 2 Reduction in S. flexnerimembrane potential and ATP levels following
IgAC5 treatment. (A) A total of 1  108 CFU of S. flexneri SJF31 per ml was
loaded with the dye JC-1, seeded in 96-well microtiter plates, and then treated
with indicated concentrations of IgAC5 (g/ml) or CCCP (M). At 2, 15, and
30 min following IgAC5 or CCCP treatment, the relative fluorescence emis-
sion signal ratios (530 nm/590 nm) were determined by using a Synergy HT
(Bio-Tek,Winooski, VT) fluorescent plate reader with dual excitation (485/20
and 530/25) and dual emission (528/20 and 590/35). The fluorescence emis-
sion ratio of control cells was set to 100%. The results are the average values
(with standard error) from a representative experiment done in triplicate. The
asterisks indicate a significant (P  0.05) reduction in membrane potential
relative to the control samples, as determined by using the Student t test
(GraphPad Software, San Diego, CA). SJF31 (tolC::kan), an isogenic deriva-
tive of strain M90T, was created using  red-mediated recombination with
pKD4 as the antibiotic resistancemarker template (26). It was necessary to use
a TolC mutant for these studies to avoid rapid expulsion of JC-1 from the cell
cytoplasm (24). (B) A total of 1 108 CFU of mid-log-phase S. flexneri strain
M90T per ml grown in minimal medium with succinate (0.5%) as the sole
carbon source was treated with a phosphate-buffered saline (PBS), IgAC5
(10 g/ml), or CCCP (100 M). At the indicated time points, total cellular
ATP levels were measured with the BacTiter-Glo (Promega, Madison, WI)
luminescence assay. The asterisks indicate significant (P 0.05) reduction in
ATP levels relative to the control samples, as determined by using the Student
t test.
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monoclonal IgA against the O-Ag (10). We have also observed
that IgAC5 treatment results in slightly elevated levels of the
periplasmic protein alkaline phosphatase (AP) in S. flexneri cul-
ture supernatants (S. Forbes and N.Mantis, unpublished results),
consistent with antibody-induced alterations in outer membrane
integrity and leakage of periplasmic proteins into the external me-
dium.
While IgAC5’s effects onT3S and bioenergetics were only tran-
sient, they could represent a significant component of IgA-
mediated immunity to S. flexneri at epithelial surfaces. We pro-
pose, for example, that IgAC5, upon first encountering S. flexneri
in vivo, may temporarily render the bacteria noninvasive. This
would then enable antibody-mediated agglutination to take place,
as well as subsequent entrapment of IgA-immune complexes in
mucus (8, 25). On another level, antibody-mediated damage to
the outermembrane could potentially make S. flexneri susceptible
to normally sublethal concentrations of antimicrobial factors
present in intestinal secretions, thereby providing a link between
the innate and adaptive immune systems at mucosal surfaces.
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